1.Conflicts with Client Activity. Subject to the exceptions below, no Security may be
purchased or sold in any Personal Securities Account seven (7) calendar days before or after
a LAM Client account trades in the same security (the “Blackout Period”).
2.Conflicts with LAM Restricted List. No Security on the LAM Restricted List may be
purchased or sold in any Personal Securities Account.
3.90 Day Holding Period. Securities transactions, including transactions in LAM Funds or
Sub-Advised Funds and any derivatives, must be for investment purposes rather than for
speculation. Consequently, subject to Section E below, Covered Persons or their Related
Persons may not purchase and sell the same Securities within ninety (90) calendar days (i.e.,
a security acquired may be sold on the 91st day but not the 89th day after acquisition),
calculated on a First In, First Out (FIFO) basis (the “90 Day Hold”). Profits from sales that
occur within the 90 Day Hold are subject to disgorgement or other sanctions pursuant to
Section J below.
4.Public Offerings. No transaction for a Personal Securities Account may be made in
Securities sold in an initial public offering or secondary offering.
5.Private Placements. Securities offered pursuant to a private placement (e.g., hedge funds,
private equity funds or any other pooled investment vehicle the interests or shares of which
are offered in a private placement) may not be purchased or sold by a Covered Person or
Related Person without the prior approval of LAM’s Chief Compliance Officer or his/her
designee. Pre-approval of such investments must be requested by Covered Persons through
the Compliance Science System. In connection with any decision to approve such a private
placement, the Legal & Compliance Department will prepare a report of the decision that
explains the reasoning for the decision and an analysis of any potential conflict of interest.
Any Covered Person receiving approval to acquire Securities in a private placement must
disclose that investment when the Covered Person participates in a subsequent consideration
of an investment in such issuer by or for a LAM Client and any decision by or made on behalf
of the LAM Client to invest in such issuer will be subject to an independent review by
investment personnel of LAM with no personal interest in the issuer.
6.Private Funds. Private funds are sold on a private placement basis and as noted above are
subject to prior approval by LAM’s Legal & Compliance Department through the
Compliance Science System. In considering whether or not to approve an investment in a
hedge fund, the Chief Compliance Officer or his or her designee, will review a copy of the
fund’s offering memorandum, subscription documents and other governing documents
(“Offering Documents”), along with any side letters, as deemed appropriate in order to
ensure that the proposed investment is being made in a manner that does not conflict with
LAM’s fiduciary duties.
Upon receipt of a request by a Covered Person to invest in a hedge fund, the Legal &
Compliance Department will contact the Fund of Funds Group (the “Team”) and identify the
fund in which the Covered Person has requested permission to invest. The Team will advise
the Legal & Compliance Department if the fund is on the Team’s approved list or if the Team